Early plasma interferon-β levels as a predictive marker of COVID-19 severe clinical events in adult patients.

MLA

Berri, Fatma, et al. “Early Plasma Interferon-β Levels as a Predictive Marker of COVID-19 Severe Clinical Events in Adult Patients.” Journal of Medical Virology, vol. 95, no. 1, Jan. 2023, p. e28361. EBSCOhost, https://doi.org/10.1002/jmv.28361.

APA

Berri, F., N’Guyen, Y., Callon, D., Lebreil, A.-L., Glenet, M., Heng, L., Pham, B.-N., Bani-Sadr, F., & Andreoletti, L. (2023). Early plasma interferon-β levels as a predictive marker of COVID-19 severe clinical events in adult patients. Journal of Medical Virology, 95(1), e28361. https://doi.org/10.1002/jmv.28361

Chicago

Berri, Fatma, Yohan N’Guyen, Domitille Callon, Anne-Laure Lebreil, Marie Glenet, Laetitia Heng, Bach-Nga Pham, Firouze Bani-Sadr, and Laurent Andreoletti. 2023. “Early Plasma Interferon-β Levels as a Predictive Marker of COVID-19 Severe Clinical Events in Adult Patients.” Journal of Medical Virology 95 (1): e28361. doi:10.1002/jmv.28361.